Fleboflex Luer Drug Compatibility & Hazardous Compounding

Fleboflex Luer has undergone extensive drug-container compatibility testing by Grifols. The polypropylene container material demonstrates superior compatibility compared to PVC — particularly for drugs known to adsorb onto PVC surfaces or that are sensitive to plasticizer leaching.

Validated drug compatibilities in 0.9% NaCl at 25 degrees C (77 degrees F) include 20 agents: Bleomycin sulfate (7 days), Carboplatin (7 days), Cisplatin (7 days), Cytarabine (7 days), Dacarbazine (1 day — protect from light), Docetaxel (7 days), Etoposide (7 days), Epirubicin (7 days), Fludarabine (7 days), Gemcitabine (7 days), Idarubicin (7 days), Ifosfamide (7 days), Irinotecan (7 days), Methotrexate (7 days), Mitoxantrone (7 days), Oxaliplatin (7 days), Paclitaxel (7 days), Vinblastine (7 days), Vincristine (7 days), and Vinorelbine (7 days).

For hazardous drug compounding, Fleboflex Luer is compatible with any Closed System Transfer Device (CSTD) that uses a Luer interface. The needle-free Luer valve provides the closed-system containment point on the bag side — no needle puncture means no open pathway for hazardous drug vapor or liquid escape during transfer.

For wellness and non-acute settings: Always verify compatibility of each additive (vitamins, minerals, NAD+, glutathione, amino acids, etc.) with both 0.9% NaCl solution and the polypropylene container before compounding. While polypropylene has superior compatibility, individual additive interactions must always be confirmed against pharmacy references.

Critical rule: Solutions containing additives must not be stored. Prepare immediately before administration and discard any unused portion. If discoloration, precipitates, insoluble complexes, or crystals appear after mixing, do NOT use — discard the entire bag and prepare fresh.